Kardigan, a heart health company modernizing cardiovascular drug development, announced positive Phase 2 data on ataciguat in patients with moderate calcific aortic valve stenosis, presented today in ...

It’s the height of meeting season! All our most-read stories this month hailed from the news team’s on-site coverage.

CMS issued a final National Coverage Determination (NCD) that green-lights renal denervation (RDN) for uncontrolled ...

LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...

PARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR® bIomimetic valve designed for physioloGic flow compared to CoMmercial TAVR devices MINNEAPOLIS and ...

Background Stroke after transcatheter aortic valve implantation (TAVI) is an infrequent but serious complication with ...

Anteris Technologies ( ($AU:AVR) ) has issued an announcement. Anteris Technologies has received FDA approval to begin the PARADIGM Trial, a ...

Objective In this study, the impact of regular training on left ventricle morphology in a group of athletes with bicuspid aortic valve (BAV) was evaluated. Design Longitudinal cohort study. A group of ...

HEMASHIELD PLATINUM Woven Double Velour Grafts are collagen-impregnated and come in straight, one-branch, or multi-branch graft configurations for aortic repair. Trusted for more than 20 years, ...

Researchers in NYU Langone’s Division of Hospital Medicine publish their studies in a wide range of peer-reviewed journals.